ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 633270 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 633270; 2) Community: the network communities that were significantly associated with the response to NSC 633270; 3) Molecule: the relationships between components within communities and NSC 633270; 4) MDR: the compounds that were significantly associated with the NSC 633270.

NSC Compound Enrichment Correlation
NSC 720299 Methyl-7.alpha.,12.alpha.-diacetoxy-5.beta.-cholan-24-oate-~ 3-spiro-6'-(1',2',4',5'-tetraoxacyclohexane)-3'-spirocyclo pentane 0.0105972823829604 0.38065049
NSC 727087 16-[4-(2-diethylaminoethoxy)3-methoxy benzylidene]-17-oxo-5-androsten-3a-yl acetate 0.0105972823829604 0.061451254
NSC 733504 Everolimus 0.0105972823829604 -0.35200021
NSC 87868 2-Phenylethyl isothiocyanate 0.0105972823829604 0.30203536
NSC 122131 Null 0.0119221520283057 0.058026101
NSC 150289 Null 0.0119221520283057 0.44105478
NSC 18335 CINERUBIN B 0.0119221520283057 0.25180956
NSC 23297 Null 0.0119221520283057 0.40667098
NSC 260594 Benzamide, 4-[(1-methyl-6-nitro-4(1H)-quinolinylidene)amino]-N-[4-[(1-methyl-4(1H)-pyridinylidene)amino]phenyl]- 0.0119221520283057 0.38429247
NSC 313157 4,7-Quinolinediamine, N(4),N(4')-1,6-hexanediylbis[N(7),N(7),2-trimethyl- 0.0119221520283057 0.50944267
Total:113  Current:41    [First] [Prev] [Next] [Last]